CaaMTech Partners with the National Institutes of Health to Study Synthetic Tryptamines
This collaboration will determine the full scope of the pharmacological effects of several synthetic tryptamine compounds.
Articles - Page 22
Antidepressant-Like Effect with A Single Dose of Ibogaine and Noribogaine in Rats
This is the first preclinical study to examine the anti-depressive effects of ibogaine and noribogaine.
Stopping Bad LSD Trips with “Off-Switch” Technology
This technology developed by MindMed and Liechti Lab may help ease some of the concerns surrounding psychedelic therapy.
Scientists Solve the Crystal Structure of the Freebase of 5-MeO-DALT
Understanding the structure of this synthetic analog of 5-MeO-DMT may help explain the effects of naturally occurring chemical cocktails.
Two New Crystalline Forms of Norpsilocin
New crystalline forms of norpsilocin create new options for developing psychedelic drug formulations.
The Structure and Function of the Serotonin 5-HT2C Receptor
5-HT2C has a role in the psychedelic effect. Understanding it is essential for harnessing the full benefits of nature’s chemical cocktails.
Brain Morphology May Help Explain Differing Psilocybin Experiences
Understanding brain morphology differences may prove essential for creating effective psychedelic drug formulations.
Hamilton Morris on 5-MeO-DMT, the Entourage Effect, and Protecting Toads
Morris has insightful ideas for studying psychedelic toad secretions while prioritizing the conservation of toads.
Habitat Influences Psychoactive Toad Secretions
Environment and diet may play a role in the alkaloid content of secretions from a Brazilian toad species.
New Biosynthesis of Psilocybin and Related Tryptamines
Researchers took the psilocybin-making genes from P. cubensis and put them into S. cerevisiae allowing them to produce psilocybin, several of its analogs, and a “new to nature” compound.